Keyphrases
Type 2 Diabetes Mellitus (T2DM)
94%
Genome-wide Association Study
89%
Meta-analysis
60%
Peroxisome Proliferator-activated Receptor
37%
Genotype
31%
Coronary Artery Disease
30%
Odds Ratio
28%
Scotland
27%
Single nucleotide Polymorphism
27%
Common Variants
26%
Diabetes
25%
Tayside
25%
Asthma
22%
Obesity
22%
Genetic Architecture
21%
European Ancestry
20%
Genetic Variants
19%
Body Mass Index
19%
Type 2 Diabetes Risk
18%
Diabetes Genetics
18%
Statins
18%
Asthma Exacerbation
18%
Blood Pressure
17%
Scottish
16%
Polymorphism
15%
Filaggrin
15%
Confidence Interval
14%
Lipids
14%
Metformin
14%
Type 2 Diabetic Patients
13%
Inhaled Corticosteroids
13%
SNP
12%
Neuropathic Pain
12%
Heart Failure
12%
Rare Variants
12%
Eczema
12%
Hemoglobin A1c (HbA1c)
12%
Genetic Variation
12%
Genome-wide Association Analysis
12%
Diversity Arrays Technology (DArT)
12%
Susceptibility Loci
12%
Older Adults
11%
Diabetes Susceptibility
11%
Genetic Risk
11%
Gain-of-function mutation
11%
Hazard Ratio
10%
Insulin Resistance
10%
Atopic Dermatitis
10%
Risk Factors
10%
Energy Intake
10%
Biochemistry, Genetics and Molecular Biology
Genome-Wide Association Study
100%
Genetics
86%
Allele
60%
Genetic Divergence
44%
Genotyping
39%
Single-Nucleotide Polymorphism
32%
Single Nucleotide Polymorphism
26%
Genomics
25%
Genetic Architecture
23%
Genome Wide Association Study
21%
Body Mass
20%
Lipid
17%
Genetic Determinism
17%
Blood Pressure
17%
Peroxisome Proliferator-Activated Receptor
16%
Statin
16%
Genetic Risk
16%
Exome
15%
Gene Locus
14%
Genetic Variation
13%
Haplotype
13%
Polygenic Score
13%
Insulin Resistance
12%
Candidate Gene
12%
Minor Allele Frequency
11%
Mendelian Randomization
10%
Genetic Association
10%
Sample Size
9%
Filaggrin
9%
Gene Expression
9%
Blood Lipids
9%
Triglyceride
8%
Pharmacogenetics
8%
Lipid Level
8%
Cytochrome P450
8%
Exome Sequencing
7%
Gene Frequency
7%
Peroxisome
7%
Cohort Study
7%
Population
6%
Agonist
6%
Amino Acids
6%
Blood Plasma
6%
HDL-Cholesterol
6%
Missense
6%
Cell Function
6%
Glucose Level
6%
Systolic Blood Pressure
6%
Penetrance
5%
Pharmacogenomics
5%